Peng Zhao
Impact in
- Infectious Diseases top 0.1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 0.2%
- Long-Term Effects of COVID-19
Papers in
-
- Glycosylation and Glycoproteins Research 22
- Plant biochemistry and biosynthesis 10
- Natural product bioactivities and synthesis 9
- Bioactive Natural Diterpenoids Research 8
-
- Phytochemistry and Biological Activities 14
- Botanical Studies and Applications 10
- Co-authors
- Zhe Xu (9 shared papers)Fu‐Sheng Wang (7 shared papers)Hongxia Liu (2 shared papers)Jinghui Dong (2 shared papers)Changqing Bai (2 shared papers)Li Zhu (1 shared paper)Lei Huang (1 shared paper)Yanhong Tai (1 shared paper)
- Journals
- Journal of Biological Chemistry (8 papers)Oncotarget (6 papers)Phytochemistry (6 papers)Fitoterapia (5 papers)Nature Communications (4 papers)
- Partner nations
- ChinaUnited StatesNorway
In The Last Decade
Peng Zhao
186 papers receiving 11.5k citations
Peng Zhao's Hit Papers
Peers
Comparison fields: 5 of 195
- Infectious Diseases 4.6k
- Neurology 2.0k
- Modeling and Simulation 280
- Critical Care and Intensive Care Medicine 212
- Molecular Biology 3.3k
Countries citing papers authored by Peng Zhao
This map shows the geographic impact of Peng Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Zhao more than expected).
Fields of papers citing papers by Peng Zhao
This network shows the impact of papers produced by Peng Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Zhao. The network helps show where Peng Zhao may publish in the future.
Co-authors
The 25 scholars most cited alongside Peng Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 192 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pathological findings of COVID-19 associated with acute respiratory distress syndrome Hit paper breakdown → | 2020 | 6084 |
| 2 | RNA-Guided RNA Cleavage by a CRISPR RNA-Cas Protein Complex Hit paper breakdown → | 2009 | 799 |
| 3 | 2020 | 395 | |
| 4 | 2020 | 300 | |
| 5 | 2011 | 180 | |
| 6 | 2011 | 133 | |
| 7 | 2014 | 94 | |
| 8 | 2016 | 89 | |
| 9 | 2020 | 87 | |
| 10 | 2016 | 79 | |
| 11 | 2017 | 78 | |
| 12 | 2023 | 75 | |
| 13 | 2009 | 73 | |
| 14 | 2020 | 68 | |
| 15 | 2021 | 67 | |
| 16 | 2016 | 67 | |
| 17 | 2012 | 62 | |
| 18 | 2012 | 61 | |
| 19 | 2021 | 60 | |
| 20 | 2018 | 59 |
About Peng Zhao
Peng Zhao is a scholar working on Molecular Biology, Plant Science, Oncology, Immunology and Infectious Diseases, having authored 192 papers that have together received 11.7k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (22 papers), Phytochemistry and Biological Activities (14 papers), Botanical Studies and Applications (10 papers), Plant biochemistry and biosynthesis (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Phytochemicals and Antioxidant Activities (9 papers), Natural product bioactivities and synthesis (9 papers) and Bioactive Natural Diterpenoids Research (8 papers). The work is most often cited by research in Infectious Diseases (4.6k citations), Neurology (2.0k citations), Modeling and Simulation (280 citations), Critical Care and Intensive Care Medicine (212 citations) and Molecular Biology (3.3k citations). Peng Zhao has collaborated with scholars based in China, United States and Norway. Frequent co-authors include Zhe Xu, Fu‐Sheng Wang, Hongxia Liu, Jinghui Dong, Changqing Bai, Li Zhu, Lei Huang, Yanhong Tai, Chao Zhang and Jin‐Wen Song. Their work appears in journals such as Journal of Biological Chemistry, Oncotarget, Phytochemistry, Fitoterapia and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.